KRX •
Healthcare •
Drug Manufacturers - Specialty & Generic •
Quote as of 05/29/2026
Company Profile
IndustryDrug Manufacturers - Specialty & Generic
SectorHealthcare
ExchangeKRX
Market Capitalization92,256 mln
Float6.76 mln
Earnings Date08/04/2025
EPS
911
Exceptional
P / E
8.47
Undervalued
Piotroski F-Score
7
/ 9
Strong
Beneish M-Score
-2.66
Likely reliable
Relative Strength
41
/ 100
Slightly lagging
Debt / Equity
1.18
Elevated leverage
Business Description
Founded in 1941 and based in Seoul, South Korea, Ildong Holdings is a diversified healthcare company that researches, produces, and sells a broad range of products including prescription drugs, vitamins, probiotics, and cosmetic ingredients such as hyaluronic acid. The company focuses its drug development efforts on serious health challenges including antibiotic resistance, cancer, Alzheimer's disease, and obesity. Beyond pharmaceuticals, Ildong distributes health supplements, beverages, medical devices, and personal care products both online and through traditional channels, while also providing technology solutions for the pharmaceutical industry.
